Pharmacists are the unsung heroes of adult respiratory vaccination. Many flu, RSV, COVID-19, and pneumococcal vaccine doses administered in pharmacies come from pharmacist recommendations—not physician referrals. Yet refusal rates exceed 60% across all four vaccine types.
ZoomRx conducted mixed-methods research combining quantitative surveys and qualitative interviews with retail pharmacists to understand this gap. The findings reveal a critical paradox: pharmacists are highly influential vaccine gatekeepers, but face three distinct barriers limiting their impact.
Understanding the Three Core Challenges Pharmacists Face in Vaccine Administration
Pharmacists face significant obstacles in administering respiratory vaccines, with research identifying three primary challenges that impact vaccination rates across the United States.
Patient Hesitancy Remains the Leading Barrier
Patient hesitancy represents the most prevalent challenge in pharmacy-based vaccination, with 90% of pharmacists identifying this as a major obstacle. According to pharmacist estimates, refusal rates following vaccine recommendations are remarkably high: 81% for COVID-19 vaccines, 80% for RSV vaccines, and 78% for pneumococcal vaccines, with influenza vaccines also experiencing significant refusal rates despite being somewhat lower.
What makes patient hesitancy particularly complex is that the reasons for declining vaccinations vary substantially by vaccine type. For RSV and pneumococcal vaccines, the top barrier is patients' preference to consult their doctor first before making a decision. COVID-19 vaccines face a different challenge, with 57% of refusals stemming from distrust in pharmaceutical companies or government recommendations—a concern that affects fewer than 25% of refusals for other vaccine types. Meanwhile, influenza vaccine hesitancy commonly stems from beliefs such as "I don't get sick" or perceptions of ineffectiveness based on past experiences of contracting flu despite vaccination.
Operational Constraints Severely Limit Vaccination Opportunities
Nearly as common as patient hesitancy, operational challenges affect 81% of pharmacists who struggle to balance vaccine administration with their regular pharmacy duties. As one pharmacist articulated, "Time is our biggest challenge... we miss the opportunity to recommend vaccines because we're so busy." These time and staffing constraints become particularly acute during peak respiratory vaccine season.
Research has identified several workflow improvements that show promise in addressing these operational barriers. Involving Immunizing Pharmacy Technicians (IPTs) in the vaccine administration process has been shown to improve efficiency and increase vaccination volumes. Similarly, Appointment-Based Models (ABMs) that allow patients to schedule vaccination appointments in advance help reduce time pressure on pharmacy staff. Technology platforms that streamline appointment scheduling, maintain vaccine records, and track co-administration opportunities also contribute to more efficient pharmacy workflows while easing pharmacist workload.
Logistical Difficulties Create Additional Friction Points
While cited less frequently than patient hesitancy or operational constraints, logistical difficulties still impact 20% of pharmacists. Supply chain challenges present a particular dilemma, as one pharmacist explained: "If demand is low, vaccine goes to waste, but sometimes demand is high and we run out."
These inventory management challenges are compounded by the need to balance high-cost vaccine inventory against unpredictable patient demand, as well as difficulties in coordinating with manufacturers and navigating frequent changes to public health guidance.
Current satisfaction with manufacturer support varies significantly. This gap reveals clear opportunities for competitive differentiation through pharmacy channel support.
Want to learn what steps vaccine manufacturers can take? Download the full whitepaper to access: